BETHESDA, Md. & ABBOTT PARK, Ill.--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced positive top-line data from a 48-week phase 3 long-term safety ...

BETHESDA, Md. & ABBOTT PARK, Ill.--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced that a pivotal phase 3 clinical trial of lubiprostone for ...

Review the side-effects of Lubiprostone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Learn everything you need to know about Lubiprostone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

BETHESDA, Md. & ABBOTT PARK, Ill.--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc. (“Sucampo”) (NASDAQ: SCMP) and Abbott (NYSE: ABT) today reported data from a phase 3 clinical efficacy trial in 124 ...

September 26, 2012 (Phoenix, Arizona) — Constipation drug lubiprostone (Amitiza, Sucampo Pharmaceuticals, Takeda Pharmaceuticals) shows efficacy and tolerability in treating opioid-induced ...

Esophagus stomach Lubiprostone was significantly more effective in improving abdominal pain or bloating than placebo, according to results from a post-hoc analysis published in Alimentary Pharmacology ...

Washington, D.C. – May 21, 2007 -- A new study demonstrated that the active ingredient in AMITIZA® (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable ...

LAS VEGAS — Constipation drug lubiprostone (Amitiza, Sucampo Pharmaceuticals, Takeda Pharmaceuticals) remains effective and well tolerated in the treatment of opioid-induced constipation (OIC) over ...

DUBLIN, Jan. 4, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized ...